Pancreatic Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Powered by

All the vital news, analysis, and commentary curated by our industry experts.


Pancreatic Cancer Pipeline Drugs Market Report Overview

Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Pancreatic Cancer – Drugs In Development, 2022, provides an overview of the Pancreatic Cancer (Oncology) pipeline landscape.

Pancreatic cancer is a disease in which malignant (cancer) cells are found in the tissues of the pancreas. This is also called exocrine cancer. Signs and symptoms include upper abdominal pain that may radiate to back, yellowing of skin and the whites of eyes (jaundice), loss of appetite, weight loss, depression and blood clots. Predisposing factors include age, gender, smoking, diabetes and family history. Treatment includes surgery, chemotherapy and radiation therapy.

Report Highlights

Global Markets Direct’s Pharmaceutical and Healthcare latest pipeline guide Pancreatic Cancer – Drugs In Development, 2022, provides comprehensive information on the therapeutics under development for Pancreatic Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Pancreatic Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Pancreatic Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Phase 0, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 1, 26, 280, 280, 10, 35, 480, 108 and 11 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Phase 0, IND/CTA Filed, Preclinical and Discovery stages comprises 27, 23, 4, 1, 71 and 12 molecules, respectively.

Pancreatic Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

* Global Markets Direct, is a research brand owned and operated by GlobalData.


– The pipeline guide provides a snapshot of the global therapeutic landscape of Pancreatic Cancer (Oncology).

– The pipeline guide reviews pipeline therapeutics for Pancreatic Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.

– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

– The pipeline guide reviews key companies involved in Pancreatic Cancer (Oncology) therapeutics and enlists all their major and minor projects.

– The pipeline guide evaluates Pancreatic Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

– The pipeline guide reviews latest news related to pipeline therapeutics for Pancreatic Cancer (Oncology)

Reasons to Buy

– Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

– Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

– Find and recognize significant and varied types of therapeutics under development for Pancreatic Cancer (Oncology).

– Classify potential new clients or partners in the target demographic.

– Develop tactical initiatives by understanding the focus areas of leading companies.

– Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.

– Formulate corrective measures for pipeline projects by understanding Pancreatic Cancer (Oncology) pipeline depth and focus of Indication therapeutics.

– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

– Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

4D Pharma Plc
A2 Biotherapeutics Inc
A28 Therapeutics Inc
AB Pharma Ltd
AB Science SA
Abbisko Cayman Limited
AbbVie Inc
Abclon Inc
Ability Pharmaceuticals SL
ABL Bio Inc
AC Bioscience SA
AcadeMab Biomedical Inc
Accendatech Co Ltd
Accuronix Therapeutics Inc
Aclaris Therapeutics Inc
Acomhal Research Inc
Actuate Therapeutics Inc
Acura Nanomedicine Inc
Adagene Suzhou Ltd
Adamed Pharma SA
ADC Therapeutics SA
Advanced BioDesign
Advenchen Laboratories LLC
Adze Biotechnology Inc
Affimed GmbH
Agastiya Biotech LLC
Agenus Inc
AGV Discovery SAS
AIkido Pharma Inc
AIM ImmunoTech Inc
Akeso Inc
Alaunos Therapeutics Inc
Algernon Pharmaceuticals Inc
Algok Bio Inc
Alissa Pharma
Alkermes Plc
Alligator Bioscience AB
Allinky Biopharma SL
Allist Shanghai Pharmaceutical Technology Co Ltd
Almac Discovery Ltd
Alphageneron-Pharmaceuticals Inc
Alphamab Oncology
AlphaVax Inc
Alpine Immune Sciences Inc
AltruBio Inc
ALX Oncology Holdings Inc
Ambrx Biopharma Inc
amcure GmbH
Amgen Inc
AmMax Bio Inc
Amphera BV
Amphivena Therapeutics Inc
Amplia Therapeutics Ltd
Anavex Life Sciences Corp
Andarix Pharmaceuticals Inc
Andes Biotechnologies
Anhorn Medicines Co Ltd
ANP Technologies Inc
Antapodia Therapeutics Inc
Antibody Therapeutics Inc
AntiCancer Inc
Anviron Corp
Apac Biotech Pvt Ltd
Apexian Pharmaceuticals Inc
Apexigen Inc
Aphios Corp
Apmonia Therapeutics SAS
Apollomics Inc
Aprilbio Co Ltd
Aravive Inc
Arbele Ltd
Arcus Biosciences Inc
Ares Immunotherapy Inc
Argonaut Therapeutics Ltd
Aria Pharmaceuticals Inc
Arovella Therapeutics Ltd
Arvinas Inc
Ascelia Pharma AB
Ascenta Therapeutics Inc
Ascentage Pharma Group International
Ascentawits Pharmaceuticals Ltd
Asclepiumm Taiwan Co Ltd
AskGene Pharma Inc
Aslan Pharmaceuticals Ltd
Astellas Pharma Inc
AstraZeneca Plc
Augustus BioTarget Inc
AUM Biosciences Pte Ltd
Aurigene Discovery Technologies Ltd
Autotac Bio Inc
Avacta Life Sciences Ltd
Avenge Bio Inc
Avenzoar Pharmaceuticals Inc
AVEO Pharmaceuticals Inc
Avican Inc
Avicenna Therapeutics Inc
B-Side Pharma Ltd
Basilea Pharmaceutica Ltd
Bavarian Nordic A/S
Bayer AG
BeiGene Ltd
Beijing Biostar Technologies Ltd
Beijing Immunochina Pharmaceuticals Co Ltd
Beijing Mabworks Biotech Co Ltd
Beijing Syngentech Co Ltd
Beijing Zheyuan Technology Co Ltd
Bellicum Pharmaceuticals Inc
Berg LLC
BerGenBio ASA
Bessor Pharma LLC
Betta Pharmaceuticals Co Ltd
Bexion Pharmaceuticals LLC
BeyondBio Inc
BeyondSpring Inc
Bicara Therapeutics Inc
Bicycle Therapeutics Plc
Bio-Path Holdings Inc
BioAtla Inc
Biocure Technology Inc
Biokine Therapeutics Ltd
BioLineRx Ltd
Biomea Fusion Inc
BioMed Valley Discoveries Inc
BioMoti Ltd
Biomunex Pharmaceuticals
BioNTech SE
Biosion Inc
Biosplice Therapeutics Inc
Biotheus Inc
BioXcel Therapeutics Inc
BJ Bioscience Inc
Blueprint Medicines Corp
Boehringer Ingelheim International GmbH
Bold Therapeutics Inc
Bolt Biotherapeutics Inc
BoYen Therapeutics Inc
BriaCell Therapeutics Corp
BrightGene Bio-Medical Technology Co Ltd
Bristol-Myers Squibb Co
C4 Therapeutics Inc
Calidi Biotherapeutics Inc
Calithera Biosciences Inc
CanBas Co Ltd
Cancer Advances Inc
Cancer Vaccines Ltd
Candel Therapeutics Inc
Canget BioTekpharma LLC
Cannabis Science Inc
Cantargia AB
Cantex Pharmaceuticals Inc
Canthera Discovery
Cardiff Oncology Inc
CARsgen Therapeutics Ltd
Cascade Prodrug Inc
CCRP Therapeutics GmbH
Celldex Therapeutics Inc
Cellectis SA
Cellid Co Ltd
CellionBioMed Inc
Cellis AG
Cellivery Therapeutics Inc
Cellix Bio Pvt Ltd
Cello Therapeutics Inc
Celprogen Inc
Celsion Corp
Cend Therapeutics Inc
Centrose LLC
Centrymed Pharmaceutical Inc
Ceptur Therapeutics Inc
CheMedImmune Inc
ChemoCentryx Inc
ChemRegen Inc
Chengdu Huitai Biomedicine Co Ltd
Chengdu Jinrui Foundation Biotechnology Co Ltd
Chia Tai Tianqing Pharmaceutical Group Co Ltd
Chimeric Therapeutics Ltd
Chimerix Inc
Chinook Therapeutics Inc
Chiome Bioscience Inc
CHO Pharma Inc
Chong Kun Dang Holdings Corp
Chongqing Precision Biotech Co Ltd
Cinkate Corp
Cloaked Therapeutics LLC
Cloud Pharmaceuticals Inc
Clovis Oncology Inc
CLS Therapeutics
CNCure Biotech Inc
CNS Pharmaceuticals Inc
COARE Biotechnology Inc
COARE Holdings Inc
Codiak BioSciences Inc
Coherent Biopharma
Corcept Therapeutics Inc
Cornerstone Pharmaceuticals Inc
Corvus Pharmaceuticals Inc
Cosmo Pharmaceuticals NV
Cotinga Pharmaceuticals Inc
Counterpoint Biomedica LLC
CPL Biologicals Pvt Ltd
CrystalGenomics Inc
CSPC Pharmaceutical Group Ltd
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd
CStone Pharmaceuticals Co Ltd
CTG Pharma Ltd
Cue Biopharma Inc
Cura Therapeutics LLC
Curegenix Inc
CureLab Oncology Inc
CureMeta LLC
Cyclacel Pharmaceuticals Inc
Cyteir Therapeutics Inc
CytImmune Sciences Inc
Cytodyn Inc
CytoImmune Therapeutics Inc
CytomX Therapeutics Inc
CytoTools AG
CyTuVax BV
D3 Bio Inc
Da Zen Theranostics Inc
DAE HWA Pharmaceutical Co Ltd
Daiichi Sankyo Co Ltd
Deciphera Pharmaceuticals Inc
DeepCure Inc
Delta-Fly Pharma Inc
DeMelle OncoPharma LLC
DevaCell Inc
Diakonos Research Ltd
Diazon Pharmaceuticals Inc
Diverse Biotech Inc
Divide and Conquer Ltd
Domain Therapeutics SA
DoricPharma LLC
Dragonboat Biopharmaceutical (Shanghai) Co Ltd
Duo Oncology Inc
DwarfBody-Therapeutics Operating Co BV
Eisai Co Ltd
Eleison Pharmaceuticals LLC
Elevation Oncology Inc
Eli Lilly and Co
Elicera Therapeutics AB
Elicio Therapeutics Inc
Ella Therapeutics Ltd
Elpis Biopharmaceuticals Corp
Elpiscience Biopharma Ltd
Elthera AG
Elucida Oncology Inc
Emmaus Life Sciences Inc
ENB Therapeutics LLC
Engitix Ltd
Ennaid Therapeutics LLC
Enochian Biosciences Inc
Epeius Biotechnologies Corp
Epidestiny Inc
Epigene Therapeutics Inc
Epizyme Inc
Erasca Inc
Esanex Inc
Escend Pharmaceuticals Inc
Esperas Pharma Inc
Essential Biotechnology LLC
Etern BioPharma Co Ltd
Etirarx LLC
Eucure (Beijing) Biopharma Co Ltd
Eureka Therapeutics Inc
Eutilex Co Ltd
EV Therapeutics Inc
Everfront Biotech Inc
Evestra Inc
Evopoint Bioscience Co Ltd
Evotec SE
Exelixis Inc
EXUMA Biotech Inc
F. Hoffmann-La Roche Ltd
Faron Pharmaceuticals Oy
Fate Therapeutics Inc
FatiAbGen Corp
Fecula Biotech Corp
Felicitex Therapeutics Inc
FibroGen Inc
FibroGenesis LLC
Flag Therapeutics Inc
Flavocure Biotech LLC
Formosa Pharmaceuticals Inc
Forte Biosciences Inc
Frontbio Co Ltd
Frontier Medicines Corp
Fujian Haixi New Medicine Creation Co Ltd
Fujifilm Holdings Corp
FUJIFILM Toyama Chemical Co Ltd
Full-Life Technologies Ltd
Fusion Pharmaceuticals Inc
GAiA BioMedicine Inc
Galera Therapeutics Inc
GamaMabs Pharma SA
Gbiologics Inc
GC Biopharma Corp
Geistlich Pharma AG
GemVax & KAEL Co Ltd
GeneCare Research Institute Co Ltd
Geneius Biotechnology Inc
Genelux Corp
Genemedicine Ltd
Genentech USA Inc
Geneos Therapeutics Inc
GeneScience Pharmaceuticals Co Ltd
Genexine Inc
GenFleet Therapeutics (Shanghai) Inc
Genisphere LLC
Genmab AS
Genomefrontier Therapeutics Inc
Genor BioPharma Co Ltd
GeoVax Labs Inc
Gilead Sciences Inc
GlycoMimetics Inc
GlycoNex Inc
GlyTherix Ltd
GO Therapeutics Inc
Golden Biotechnology Corp
Gradalis Inc
Gritstone Bio Inc
GSK plc
GT Biopharma Inc
Guangdong Zhongsheng Pharmaceutical Co Ltd
Guangzhou BeBetter Medicine Technology Co Ltd
Guangzhou Sinogen Pharmaceutical Co Ltd
H2Biologics Inc
HaimBio Ltd
Hangzhou Bensheng Pharmaceutical Co Ltd
Hangzhou DAC Biotech Co Ltd
Hangzhou Neoantigen Therapeutics Co Ltd
Hangzhou Weiben Pharmaceutical Co Ltd
Hanmi Pharmaceuticals Co Ltd
Harbin Gloria Pharmaceuticals Co Ltd
Harpoon Therapeutics Inc
HCW Biologics Inc
Hebei Senlang Biotechnology Co Ltd
Heidelberg Pharma AG
Helix BioPharma Corp
Helixmith Co Ltd
Hibercell Inc
Hinova Pharmaceuticals Co Ltd
Hookipa Pharma Inc
HRYZ (ShenZhen) Biotech Co
Huabo Biopharm (Shanghai) Co Ltd
Hummingbird Bioscience Pte Ltd
Hutchison MediPharma Ltd
Hyundai Bioscience Co Ltd
i2 Pharmaceuticals Inc
Icell Kealex Therapeutics LLC
Ideaya Biosciences Inc
Idera Pharmaceuticals Inc
Ikena Oncology Inc
ImCheck Therapeutics SAS
Immix BioPharma Inc
Immodulon Therapeutics Ltd
Immune Biosolutions Inc
Immune System Key Ltd
Immuneering Corp
ImmuneOnco Biopharmaceuticals (Shanghai) Co Ltd
Immunitor Inc
ImmunityBio Inc
Immunocore Holdings Plc
Immunogenesis Inc
Immunos Therapeutics AG
Immunovo BV
ImmunSYS Inc
Immupharma Plc
Immvira Co Ltd
Imugene Ltd
Imvax Inc
Incanthera Plc
Incyte Corp
Indaptus Therapeutics Inc
Indi Molecular Inc
Inflection Biosciences Ltd
Inhibrx Inc
Innate Pharma SA
InnoCure Therapeutics Inc
Innopharmax Inc
Innova Therapeutics Inc
Innovation Pharmaceuticals Inc
Innovative Cellular Therapeutics Co Ltd
Innovent Biologics Inc
Innovimmune Biotherapeutics Inc
Inovio Pharmaceuticals Inc
Inspirna Inc
Intensity Therapeutics Inc
InteRNA Technologies BV
Intrepida Bio Inc
Inventiva SA
Invion Ltd
InvivoGen Therapeutics
InxMed (Beijing) Co Ltd
IO Biosciences Inc
Io Therapeutics Inc
iOnctura SA
Ionic Pharmaceuticals LLC
Ionova Life Science Co Ltd
Iovance Biotherapeutics Inc
Ipsen SA
J-Pharma Co Ltd
Jacobio Pharmaceuticals Group Co Ltd
January Therapeutics Inc
JenKem Technology Co Ltd
Jiangsu Aosaikang Pharmaceutical Co Ltd
Jiangsu Hengrui Medicine Co Ltd
Jivana Biotechnology Inc
Johnpro Biotech Inc
Johnson & Johnson
Kalos Therapeutics Inc
Kalyra Pharmaceuticals Inc
Kangen Pharmaceuticals Co Ltd
Kanyr Pharma Inc
Karyopharm Therapeutics Inc
KeyMed Biosciences Inc
KinaRx LLC
Kiromic BioPharma Inc
KLUS Pharma Inc
Kodikaz Therapeutic Solutions Inc
Kringle Pharma Inc
Kupffer Biotherapeutics Inc
Kymab Ltd
Kyowa Kirin Co Ltd
L.E.A.F. Pharmaceuticals LLC
LA Cell Inc
Laevoroc Oncology AG
LaNova Medicines Ltd
Lantern Pharma Inc
Le Sun Pharmaceuticals Ltd
Lead Discovery Center GmbH
Lee's Pharmaceutical Holdings Ltd
Legend Biotech Corp
LegoChem Biosciences Inc
Les Laboratoires Servier SAS
LIfT BioSciences Ltd
Liminal BioSciences Inc
Liminatus Pharma LLC
Lin Bioscience Inc
Linnaeus Therapeutics Inc
Lipomedics Ltd
LipoMedix Pharmaceutical Inc
LipoSeuticals Inc
Lixte Biotechnology Holdings Inc
Loki Therapeutics Inc
Lokon Pharma AB
Loxo Oncology Inc
Luminus Biosciences Inc
Lumobiotics GmbH
Lumosa Therapeutics Co Ltd
Luye Pharma Group Ltd
Lyvgen Biopharma Ltd
MabVax Therapeutics Holdings Inc
Machavert Pharmaceuticals LLC
MacroGenics Inc
MAIA Biotechnology Inc
Marino Biotechnology Co Ltd
Marker Therapeutics Inc
Maverick Therapeutics Inc
Max Biopharma Inc
Meabco AS
MedAnnex Ltd
MediaPharma SRL
Medical Guidance Systems LLC
Medicenna Therapeutics Corp
MediciNova Inc
Medicon Pharmaceuticals Inc
MedPacto Inc
Mekanistic Therapeutics LLC
Memgen Inc
Merck & Co Inc
Merck KGaA
Mereo Biopharma Group Plc
Merus NV
MetiMedi Pharmaceuticals Co Ltd
Metis Precision Medicine
Migra-Therapeutics LLC
Millennium Pharmaceuticals Inc
Mina Therapeutics Ltd
Minneamrita Therapeutics LLC
Mirati Therapeutics Inc
Mito BioPharm LLC
Moderna Inc
Modulus Oncology Ltd
Mogrify Ltd
Molecular Partners AG
Molecular Templates Inc
Moleculin Biotech Inc
Momotaro-Gene Inc
Monopar Therapeutics Inc
Multitude therapeutics Inc
Mundipharma EDO GmbH
Mustang Bio Inc
Mycenax Biotech Inc
Nanjing Bioheng Biotech Co Ltd
Nanjing CART Medical Technology Co Ltd
Nanocan Therapeutics Corp
NanoCarrier Co Ltd
Nanogenics Ltd
Nanology LLC
NanoPharmaceuticals LLC
NantBioScience Inc
Nascent Biotech Inc
Navire Pharma Inc
NB Health Laboratory Co Ltd
Nelum Corp
NeoTX Therapeutics Ltd
Nerviano Medical Sciences SRL
NeuBase Therapeutics Inc
New Beta Innovation Ltd
NewG Lab Pharma Co Ltd
NewG Lab Pharma Inc
NextCure Inc
NGM Biopharmaceuticals Inc
Nitto BioPharma Inc
NomoCan Pharmaceuticals LLC
NovalGen Ltd
NovaRock Biotherapeutics Inc
Novartis AG
Novita Pharmaceuticals Inc
NOX Pharmaceuticals Inc
Noxopharm Ltd
NuGenerex Immuno-Oncology Inc
Nuvation Bio Inc
OBI Pharma Inc
Oceanyx Pharmaceuticals Inc
Ocuphire Pharma Inc
Oleolive LLC
Omeros Corp
OncoC4 Inc
Oncocross Co Ltd
Oncodesign SA
Oncology Research International Ltd
Oncolys BioPharma Inc
Oncolytics Biotech Inc
Oncomatryx Biopharma SL
Onconic Therapeutics Co Ltd
OncoOne Research & Development GmbH
OncoQuest Inc
OncoSec Medical Inc
OncoSynergy Inc
OncoTAb Inc
Oncotelic Therapeutics Inc
OncoTherapy Science Inc
OncoTherics Ltd
OncoTrap Inc
Oncovir Inc
OncXerna Therapeutics Inc
Oneness Biotech Co Ltd
Ono Pharmaceutical Co Ltd
OPKO Health Inc
Optimum Therapeutics LLC
Orano Med LLC
Oregon Therapeutics
Orgenesis Inc
OS Therapies LLC
OSE Immunotherapeutics SA
Otsuka Holdings Co Ltd
Palisades Therapeutics
Palleon Pharmaceuticals Inc
Panbela Therapeutics Inc
PanTher Therapeutics Inc
Patrys Ltd
PAZ Pharma
PendreaBio Inc
Penrose Therapeutix LLC
PersonGen BioTherapeutics (Suzhou) Co Ltd
Pfizer Inc
Phanes Therapeutics Inc
Pharma Mar SA
PharmAbcine Inc
PharmaCyte Biotech Inc
Pharmaxis Ltd
Phenex Pharmaceuticals AG
pHion Therapeutics Ltd
Phoenix Biotechnology Inc
Phoenix Life Sciences International Ltd
Pieris Pharmaceuticals Inc
Pionyr Immunotherapeutics Inc
Plexxikon Inc
Plus Therapeutics Inc
PNB Vesper Life Science Pvt Ltd
POINT Biopharma Global Inc
POP Biotechnologies Inc
Portage Biotech Inc
Poseida Therapeutics Inc
Precision Biologics Inc
Prescient Therapeutics Ltd
Prestige BioPharma Ltd
Primary Peptides Inc
PRISM Pharma Co Ltd
ProCell Therapeutics Inc
Processa Pharmaceuticals Inc
ProDa BioTech LLC
Promontory Therapeutics Inc
Propanc Biopharma Inc
Provectus Biopharmaceuticals Inc
Psivac Ltd
Puma Biotechnology Inc
Purdue Pharma LP
Puretech Health Plc
Purple Biotech Ltd
Qilu Pharmaceutical Co Ltd
Qu Biologics Inc
Quadriga BioSciences Inc
Qualigen Therapeutics Inc
Quest PharmaTech Inc
Quimatryx SL
Qurgen Inc
Qurient Co Ltd
Qwixel Therapeutics LLC
RadImmune Therapeutics Inc
Ranger Biotechnologies AS
Recordati SpA
Redbiotec AG
RedHill Biopharma Ltd
Redx Pharma Plc
Regeneron Pharmaceuticals Inc
RemeGen Co Ltd
Repare Therapeutics Inc
Resonant Therapeutics Inc
Reven Holdings Inc
Revolution Medicines Inc
Rhizen Pharmaceuticals SA
Rigenerand Srl
Rimo Therapeutics Inc
Riptide Bioscience Inc
Rise Biopharmaceutical Ltd
RS Research
Rubius Therapeutics Inc
Sagetis Biotech SL
Sagimet Biosciences Inc
Salarius Pharmaceuticals Inc
Salspera LLC
Samyang Biopharmaceuticals Corp
Sapphire Biotech Inc
Sareum Holdings Plc
Savoy Pharmaceuticals Inc
Scancell Holdings Plc
Scandion Oncology AS
ScarTec Therapeutics BV
Schrodinger Inc
Seagen Inc
SEEKYO Therapeutics
Segue Therapeutics LLC
SELLAS Life Sciences Group Inc
Senhwa Biosciences Inc
Seven and Eight Biopharmaceuticals Corp
Shandong Boan Biotechnology Co Ltd
Shanghai Biomed-Union Biotechnology Co Ltd
Shanghai Bioray Laboratory Inc
Shanghai Escugen Biotechnology Co Ltd
Shanghai First Song Therapeutics Co Ltd
Shanghai Fosun Pharmaceutical (Group) Co Ltd
Shanghai Gencells Therapeutics Co Ltd
Shanghai GeneChem Co Ltd
Shanghai Haihe Biopharma Co Ltd
Shanghai Huilun Life Science & Technology Co Ltd
Shanghai Iron Biological Technology Co Ltd
Shanghai Junshi Bioscience Co Ltd
Shanghai Longyao Biotechnology Co Ltd
Shanghai Miracogen Inc
Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
Shanghai Yihao Biotechnology Co Ltd
Shanghai Yingli Pharmaceutical Co Ltd
Shenogen Pharma Group Ltd
Shenzhen BinDeBio Ltd
Shenzhen Hepalink Pharmaceutical Group Co Ltd
Shenzhen Lingfang Biomedical Technology Co Ltd
Shijiazhuang Sagacity New Drug Development Co Ltd
Shijiazhuang Yiling Pharmaceutical Co Ltd
Shouyao Holding Co Ltd
Sichuan Kelun Pharmaceutical Co Ltd
Signablok Inc
SignalChem Lifesciences Corp
SignalRx Pharmaceuticals Inc
Silenseed Ltd
Sillajen Biotherapeutics
Singh Biotechnology LLC
Sino Biopharmaceutical Ltd
siRNAgen Therapeutics Corp
Sirnaomics Ltd
SIRPant Immunotherapeutics Inc
Siwa Therapeutics Inc
SN BioScience
Soluventis Nanotherapeutics
Sonoval LLC
Soricimed Biopharma Inc
Sorrento Therapeutics Inc
SOTIO Biotech AS
SpringWorks Therapeutics Inc
Starpharma Holdings Ltd
Statera Biopharma Inc
Stcube Inc
Stellanova Theraputics Inc
Stemirna Therapeutics Ltd
Stromacare SAS
Sublime Therapeutics
Sun Pharma Advanced Research Company Ltd
Surface Oncology Inc
Suzhou Dingfu Target Biotechnology Co Ltd
Suzhou GenHouse Pharmaceutical Co Ltd
Suzhou Zelgen Biopharmaceutical Co Ltd
Suzhou Zerun New Drug Research and Development Co Ltd
Swedish Orphan Biovitrum AB
Symphogen A/S
SynCore Biotechnology Co Ltd
Syndivia SAS
SynerGene Therapeutics Inc
Synovo GmbH
SynOx Therapeutics Ltd
SyntheX Inc
Syntrix Pharmaceuticals
Syros Pharmaceuticals Inc
T-Cure Bioscience Inc
TAE Life Sciences LLC
Taiho Oncology Inc
Taiho Pharmaceutical Co Ltd
Tailored Therapeutics LLC
Takeda Pharmaceutical Co Ltd
Takis Srl
TargaGenix Inc
Targazyme Inc
Targovax ASA
Tarveda Therapeutics Inc
TCR2 Therapeutics Inc
Telesis Therapeutics LLC
Telix Pharmaceuticals Ltd
tella Inc
Tempest Therapeutics Inc
TenCure Ltd
Tessa Therapeutics Ltd
Tevogen Bio Inc
TEZCAT Laboratories LLC
The National Institute for Biotechnology in the Negev Ltd
Therabest Co Ltd
Theralink Technologies Inc
TherapyX Inc
TheRas Inc
Theratechnologies Inc
Theravectys SA
Thetis Pharmaceuticals LLC
Tianjin Hengjia Biotechnology Development Co Ltd
TILT Biotherapeutics Ltd
Tiziana Life Sciences Plc
TME Pharma AG
Tmunity Therapeutics Inc
Tonix Pharmaceuticals Holding Corp
TOT Biopharm Co Ltd
Transcenta Holding Ltd
Transcode Therapeutics Inc
Transcriptogen Ltd
Transgene SA
Transtarget Inc
Treadwell Therapeutics Inc
Trio Medicines Ltd
TriSalus Life Sciences Inc
Trishula Therapeutics Inc
Turning Point Therapeutics Inc
TVAX Biomedical Inc
Tyg Oncology Ltd
UbiVac LLC
V2ACT Therapeutics LLC
Vaccinex Inc
VacV Biotherapeutics Ltd
ValiRx Plc
Valiseek Ltd
Vanquish Oncology Inc
VasGene Therapeutics Inc
Vault Pharma Inc
VaxcellBio Inc
Vaximm AG
VCN Biosciences SL
Vect-Horus SAS
Veltion Therapeutics LLC
Venus Remedies Ltd
Verastem Inc
Verismo Therapeutics
Verra Therapeutics LLC
Vertex Pharmaceuticals Inc
Veru Inc
VGI Health Technology Ltd
Vigeo Therapeutics Inc
Virogin Biotech Ltd
ViroStatics SRL
Vitalgenics Inc
Vivacitas Oncology Inc
Vivesto AB
VM Discovery Inc
Voronoi Group
Wellington Zhaotai Therapies Ltd
WellMarker Bio Co Ltd
Westwood Bioscience Inc
Window Therapeutics Inc
Wntrix Inc
Worphmed Srl
Wuhan Binhui Biotechnology Co Ltd
XBiotech Inc
Xencor Inc
Xi'An Yufan Biotechnology Co Ltd
XuanZhu Biological Technology Co Ltd
Yisheng Biopharma Co Ltd
Zai Lab Ltd
Zelira Therapeutics Ltd
Zelluna Immunotherapy AS
Zenith Epigenetics Ltd
Zhejiang Borui Biopharmaceutical Co Ltd
Zhejiang Doer Biologics Corp
Zhejiang Teruisi Pharmaceutical Co Ltd
Zhejiang Yangshengtang Biotech Co Ltd
ZielBio Inc
Zonula Inc
Zovis Pharmaceuticals
Zucero Therapeutics Ltd
Zymergen Inc
ZyVersa Therapeutics Inc

Table of Contents

Table of Contents

List of Tables

List of Figures


Global Markets Direct Report Coverage

Pancreatic Cancer – Overview

Pancreatic Cancer – Therapeutics Development

Pipeline Overview

Pipeline by Companies

Pipeline by Universities/Institutes

Products under Development by Companies

Products under Development by Universities/Institutes

Pancreatic Cancer – Therapeutics Assessment

Assessment by Target

Assessment by Mechanism of Action

Assessment by Route of Administration

Assessment by Molecule Type

Pancreatic Cancer – Companies Involved in Therapeutics Development

Pancreatic Cancer – Drug Profiles

Pancreatic Cancer – Dormant Projects

Pancreatic Cancer – Product Development Milestones

Featured News & Press Releases




Secondary Research

Primary Research

Expert Panel Validation

Contact Us


Frequently asked questions

Pancreatic Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update thematic reports
Currency USD

Can be used by individual purchaser only


Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS

Related reports

View more Oncology reports
Innovation in pharma: transdermal drug delivery
$250 | November 2023
Synthetic Biology - Thematic Intelligence
$995 | November 2023
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Pancreatic Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update in real time.

  • Access a live Pancreatic Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.